Compugen (CGEN) EBITDA Margin (QoQ) (2009 - 2026)
Compugen (CGEN) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,115.00 |
| Dec 31, 2025 | 50,063.00 |
| Sep 30, 2025 | 158,889.00 |
| Jun 30, 2025 | -237,384.00 |
| Mar 31, 2025 | 87,626.00 |
| Dec 31, 2024 | -53,494.00 |
| Sep 30, 2024 | 33,057.00 |
| Jun 30, 2024 | -63,618.00 |
| Mar 31, 2024 | 27,810.00 |
| Dec 31, 2016 | -510,348.00 |
| Sep 30, 2016 | -996,853.00 |
| Jun 30, 2016 | 812,581.00 |
| Mar 31, 2016 | -952,996.00 |
| Dec 31, 2015 | 301,047.00 |
| Sep 30, 2015 | 9,872.00 |
| Jun 30, 2015 | -188,558.00 |
| Mar 31, 2015 | -121,534.00 |
| Dec 31, 2014 | 25,033.00 |
| Sep 30, 2014 | -9,840.00 |
| Jun 30, 2014 | -1,371.00 |